Gunzburg announced the start of clinical trials of a vaccine for children

Clinical trials of a vaccine against covid-19 for children aged six to 11 will begin soon, and relevant agreements have already been concluded. This was announced by the DIRECTOR of the Center. N.F. Gamalei Alexander Gintsburg, reports TASS.

“I signed contractual documents on this issue with companies that will conduct research. They are about to start, we can wait in the near future, ”he said.

At the end of November 2021, the Russian Ministry of HEALTH registered the Sputnik M drug, which will be vaccinated in adolescents aged 12 to 17 years. Tests of the vaccine have been going on since July at 12 Moscow children's medical institutions. Gunzburg said that the only side effect in adolescents in the study was fever.

“The maximum rise in temperature, as far as I remember, was 37.4. No more side effects were found in the children who were in the study, ”said the director of the Center. N.F. Gamaleya.